They also reported that ASNS expression is induced by KRAS activation signaling, particularly via PI3K-AKT-mTOR signaling, and that a combination of ASNase and mTOR inhibitor suppresses the growth of KRAS-mutant CRC cells in vivo [61]. Here, KRAS is linked to colorectal carcinoma.